Michael Manogue, MD
Clinical Cardiac Electrophysiology · Asheville, NCNPI 1417183054
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $168,627 of the $230,063 with a category attached, or 73.3%. Boston Scientific accounts for 67.8% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $146,510, more than ten times the $4,187 reported in 2019. Among clinical cardiac electrophysiology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 560 payments — averaging $410.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$156K
- Medtronic$68K
- Biosense Webster, Inc.$4K
- Abbott$695
- Atricure, Inc.$486
- Biotronik Inc.$382
- plus $1K from 15 others
Across 6 payments — averaging $1108.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$7K
What the payments were for
- Consulting fees$25,68811%
- Speaking & faculty fees$168,62773%
- Travel & lodging$15,6817%
- Food & beverage$19,9479%
- Education$1200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 177 | $155,883 |
| Medtronic(2 entities) | 274 | $67,558 |
| Biosense Webster, Inc. | 21 | $3,754 |
| Abbott | 11 | $695 |
| Atricure, Inc. | 10 | $486 |
| Biotronik Inc. | 5 | $382 |
| Actelion Pharmaceuticals US, Inc. | 15 | $258 |
| Vektor Medical Inc. | 1 | $252 |
| Pfizer | 8 | $168 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $115 |
| Johnson & Johnson | 9 | $115 |
| Boehringer Ingelheim | 3 | $85 |
| Amarin Pharma, Inc. | 3 | $56 |
| Terumo Medical Corporation | 1 | $46 |
| E.r. Squibb & Sons, L.L.C. | 2 | $44 |
| Amgen | 3 | $38 |
| United Therapeutics Corporation | 2 | $32 |
| Cardiva Medical, Inc. | 2 | $28 |
| Novartis | 2 | $27 |
| Edwards Lifesciences | 1 | $21 |
| Bayer | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL EP$99,839
- Farapulse$9,015
- Rhythmia Mapping System$7,616
- SelectSecure$7,156
- Cable, IntellaNav Ablation Catheter$4,000
- GENERAL - THERAPIES$3,651
- Arctic Front$3,222
- Carto 3$2,699
- RHYTHMIA$1,083
- Micra$1,016
- AZURE XT DR MRI SURESCAN$367
- ENSITE$344
- WATCHMAN Access System$293
- Acticor 7 VR-T DX$284
- BioMonitor$284
- vMap$252
- COBALT DR MRI SURESCAN$237
- ENSITE PRECISION$190
- AFFERA MAPPING SYSTEM$168
- ARCTIC FRONT ADVANCE$165
How this compares
$230,063 in reported general payments places this provider in the 95th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.
See all clinical cardiac electrophysiology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 242 | $260,945 |
| XareltoRivaroxaban | 114 | $135,741 |
| EntrestoSacubitril/Valsartan | 42 | $35,548 |
| MultaqDronedarone Hcl | 15 | $30,415 |
| Dofetilide | 154 | $21,977 |
| JardianceEmpagliflozin | 14 | $10,183 |
| Metoprolol Succinate | 157 | $3,497 |
| Flecainide Acetate | 38 | $1,404 |
| Clonidine | 12 | $927 |
| Amiodarone Hcl | 84 | $907 |
| Mupirocin | 118 | $856 |
| Atorvastatin Calcium | 41 | $655 |
| Spironolactone | 55 | $503 |
| SotalolSotalol Hcl | 32 | $448 |
| Lisinopril | 41 | $445 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $168 | $260,945242 claims |
| Johnson & JohnsonXarelto | $115 | $135,741114 claims |
| NovartisEntresto | $27 | $35,54842 claims |
| Boehringer IngelheimJardiance | $85 | $10,18314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.
Other clinical cardiac electrophysiology in Asheville
- John RhynerAsheville$168K
- Joseph DonnellyAsheville$73K
- Zachary HaleAsheville$56K
- John BrandtAsheville$39K
- Daniel FriedmanDurham$196K
- James AllredGreensboro$184K
- Gregory HarrisGreenville$164K
- John CatanzaroGreenville$159K
- Kevin ManochaRaleigh$146K
- Albert SunDurham$138K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.